Cell-based assays in drug discovery: the key to faster cures? скачать в хорошем качестве

Cell-based assays in drug discovery: the key to faster cures?

The drug development process is a long one, and rightfully so for safety reasons. But what if you could shave months off the drug discovery workflow, simultaneously saving time, hassle, and increasing efficiency and safety? In this video, we explain how automated processes can remove manual bottlenecks in cellular assays. Whether they deal with killing, immunophenotyping, activation, receptor binding, migration, phagocytosis, cytokines, proteogenomics, or many other applications, Miltenyi Biotec drug discovery solutions cover sample preparation, cell isolation, culture, and analysis with high degrees of automation and exhaustive validation. If you work with cells in the drug discovery and development process, you really need to be talking to us: by eliminating unnecessary bottlenecks, we can help you save more lives, faster. Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies enable solutions for cellular research, cell therapy, cell manufacturing, and imaging.. Our 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec more than 3,000 employees in 28 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.